| Model Number |
FR8A-SPR-B0, FR8A-RCV-A0 |
| Medical Device Problem Codes |
Adverse Event Without Identified Device or Use Problem (2993); Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Code |
Pain (1994)
|
| Date of Event |
01/05/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The unintended stimulation/new pain questionnaire was reviewed for potential causes of the reported issue.Based on this review, the script was completed with limited information.Potential causes of new pain are migration, improper programming parameters, change in posture or proximity of electrodes to target nerve resulting in stimulation of nerves outside of the target nerve, and patient contraindicating conditions.A review of sterilization and packaging records for the respective product lot; it was confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.The cause of the reported issue is unknown.Therefore, conclusion has been selected as no problem/fault found.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in unintended stimulation/new pain issues.Unintended stimulation/new pain issue rates remain acceptably low; thus, capa is not required. unintended stimulation/new pain issue rates will continue to be tracked and trended.
|
| |
|
Event or Problem Description
|
|
The patient reported excruciating pain and a difficult procedure.The clinical representative and customer support conducted multiple attempts to contact the patient.However, the attempts were unsuccessful.
|
| |
|
Additional Manufacturer Narrative
|
|
The unintended stimulation/new pain questionnaire was reviewed for potential causes of the reported issue.Based on this review, the script was completed with limited information.Potential causes of new pain are migration, improper programming parameters, change in posture or proximity of electrodes to target nerve resulting in stimulation of nerves outside of the target nerve, and patient contraindicating conditions.A curonix representative conducted a review of sterilization and packaging records for the respective product lot; curonix has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.The cause of the reported issue is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, conclusion has been selected as unable to determine root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in unintended stimulation/new pain issues.Unintended stimulation/new pain issue rates remain acceptably low; thus, capa is not required. unintended stimulation/new pain issue rates will continue to be tracked and trended.Updated per fda capa-2023-0013 correction 2.
|
| |
|
Event or Problem Description
|
|
The patient reported excruciating pain and a difficult procedure.The clinical representative and customer support conducted multiple attempts to contact the patient.However, the attempts were unsuccessful.
|
| |
|
Search Alerts/Recalls
|